Diligence memo · auto-generated · as of July 2, 2026

Innovation Specialists Llc

Innovation Specialists Llc looks under-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Innovation Specialists Llc operates in Other Health Care, based in HOUSTON.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Innovation Specialists Llc has raised $3.5M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $1.7M on 2012-01-01.

Most recent recorded round closed around 2016-04-15.

Valuation (modeled)modeled

Provath models Innovation Specialists Llc at approximately $15M (range $529K–$122M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.35× the median modeled value of Seed Other Health Care companies in 2016–2018 (222 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 30 months.

Last raise 10.2 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 2.7× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 58% of Other Health Care peers (5377 compared).

Modeled value ranks above 44% of those peers.

Closest niche peers: Eye Academy of America Ltd., Ruddco Inc., Guest House Holdings, LLC, Cb Therapeutics Inc., Shift Sciences, LLC.

Peoplefiled

4 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.